1. Moneret-Vautrin DA, Mertes PM. Anaphylaxis to general anesthetics. Chem Immunol Allergy. 2010;95:180-9.

2. Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018;121(1):159‑71.

3. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125:S161‑81.

4. Montañez MI, Mayorga C, Bogas G, Barrionuevo E, FernandezSantamaria R, Martin-Serrano A, et al. Epidemiology, mechanisms, and diagnosis of Drug-induced anaphylaxis. Front Immunol. 2017;8:614.

5. Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017;140:335-48.

6. Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT. Molecular mechanisms of anaphylaxis: Lessons from studies with murine models. J Allergy Clin Immunol. 2005; 115:409-57.

7. Steenholdt C, Svenson M, Bendtzen K, Thomsen OØ, Brynskov J, Ainsworth MA. Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn’s disease. J Crohns Colitis. 2012;6:108‑11.

8. Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003;98:1315‑24.

9. Navines-Ferrer A, Serrano-Candelas E, Lafuente A, Munoz-Cano R, Martin M, Gastaminza G. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Report. 2018;8:11628.

10. Munõz-Cano R, Pascal M, Araujo G, Goikoetxea MJ, Valero AL, Picado C, et al. Mechanisms, cofactors, and augmenting factors involved in anaphylaxis. Front Immunol. 2017;8:1193.

11. Galvão VR, Giavina-Bianchi P, Castells M. Perioperative anaphylaxis. Curr Allergy Asthma Rep. 2014;14(8):452.

12. Rocha JF. Cómo hacer frente a una reacción alérgica en el perioperatorio: del rash a la anafilaxia. Rev Med Aeronaut. 2013;36:S288-90.

13. Soetens FM. Anaphylaxis during anaesthesia: diagnosis and treatment. Acta Anaesthesiol Belg. 2004;55:229-37.

14. Kannan JA, Bernstein JA. Perioperative anaphylaxis: diagnosis, evaluation, and management. Immunol Allergy Clin North Am. 2015;35(2):321-34.

15. Dewachter P, Mouton-Faivre C, Hepner DL. Perioperative anaphylaxis: what should be known? Curr Allergy Asthma Rep. 2015;15:21.

16. McAleer PT, McNicol L, Rose MA. Perioperative anaphylaxis: progress, prevention and pholcodine policy. Anaesth Intensive Care. 2017;45(2):147-50.

17. Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy. 2010;95:12-21.

18. Freundlich RE, Duggal NM, Housey M, Tremper TT, Engoren MC, Kheterpal S. Intraoperative medications associated with hemodynamically significant anaphylaxis. J Clin Anesth. 2016;35:415-23.

19. Escolano F, Valero A, Huguet J, Baxarias P, de Molina M, Castro A, et al. Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7). Rev Esp Anestesiol Reanim. 2002;49(6):286-93.

20. Mertes PM, Lambert M, Guéant-Rodriguez RM, Aimone-Gastin I, Mouton-Faivre C, Moneret-Vautrin DA, et al. Perioperative Anaphylaxis. Immunol Allergy Clin N Am. 2009;29:429‑51.

21. Freeman SG, Love NJ, Misbah SA, Pollard RC. Impact of national guidelines on reporting anaphylaxis during anaesthesia – an outcome audit. Acta Anaesthesiol Scand. 2013;57(10):1287-92.

22. Mertes PM, Alla F, Tréchot P, Auroy Y, Jougla E, Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: An 8-year national survey, J Allergy Clin Immunol. 2011;128: 366-73.

23. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy. 2014;69:1582‑7.

24. Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD, Olivera A. Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol. 2015;135:729‑36.

25. Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, et al. Plateletactivating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008;358:28‑35.

26. Turner P, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boy RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5:1169-78.

27. Mertes PM, Ebo DG, Garcez T, Rose M, Sabato V, Takazawa T, et al. Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth. 2019;123(1):e16-e28.

28. Garvey LH, Ebo DG, Mertes PM, Dewachter P, Garcez T, Kopac P, et al. An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions. Allergy. 2019;74(10):1872‑84.

29. Garro LS, Aun MV, Soares IS, Ribeiro MR, Motta AA, Kalil JA, et al. Specific questionnaire detects a high incidence of intra-operative hypersensitivity reactions. Clinics. 2018;113:1202-12.

30. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature. 1983;306:262-4.

31. Baldo BA, Fisher MM. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant.) drugs: an immunochemical perspective. Clin Exp Allergy. 2009; 39:325-44.

32. Florvaag E, Johansson SGO. The pholcodine case. Cough medicines, IgE-sensitization and anaphylaxis: a devious connection. World Allergy Organ J. 2012;5(7):73-8.

33. Antunes J, Kochuyt AM, Ceuppens Jl. Perioperative allergic reactions: experience in a Flemish referral centre. Allergol Immunopathol (Madr). 2014:42:348-54.

34. Spoerl D, NIgolian H, Czarnetzki C, Harr T. Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed pathomechanism: IgE-mediated, pharmacological adverse reaction or “innate hypersensitivity”? Int J Mol Sci. 2017;18:1223.

35. Chiriac AM, Tacquard C, Fadhel BN, Pellerin C, Malinovsky JM, Mertes PM, et al. Safety of subsequent general anesthesia in patient allergic to neuromuscular blocking agents: value of allergy skin testing. Br J Anaesth. 2018;120:1437-40.

36. Fraser BA, Smart JA. Anaphylaxis to cisatracurium following negative skin testing. Anaesth Intensive Care. 2005;33:816-9.

37. Scolaro RJ, Crilly HM, Maycock EJ, McAleers PT, Nicholls KA, Rose MA, et al. The Australian and New Zealand anaesthetic allergy group perioperative anaphylaxis investigation guidelines. Anaesth Intensive Care. 2017;45(5):543-55.

38. Leysen J, Bridts CH, De Clerk LS, Ebo DG. Rocuronium-‑induced anaphylaxis is probably not mitigated by sugammadex:evidence from an in vitro experiment. Anaesthesia. 2011;66:526-7.

39. Clarke RC, Sadleir PH, Platt PR. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia. 2012;67:266-73.

40. Platt PR, Clarke RC, Jonson GH, Sadleir PH. Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A casecontrol study. Anaesthesia. 2015;70:1264-7.

41. Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia. 2014;69:1251-7.

42. Garvey LH, Dewachter P, Hepner DL, Mertes PM, Voltolini S, Clarke R, et al. Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations. Br J Anaesth. 2019;123(1):e50-e64.

43. Volcheck GW, Hepner DL. Identification and management of perioperative anaphylaxis. J Allergy Clin Immunol Pract. 2019;7:2134-42.

44. Blaabjerg MS, Andersen KE, Bindeslev-Jensen C, Mortz CG. Decrease in the rate of sensitization and clinical allergy to natural rubber latex. Contact Dematitis. 2015;73:21-8.

45. Cremer R, Lorbacher M, Hering F, Engelskirchen R. Natural rubber latex sensitization and allergy in patients with spina bífida, urogenital disorders and oesophageal atresia compared with normal paediatric population. Eur J Pediatr Surg. 2007;17:194-8.

46. Michavila Gomez AV, Belver Gonzalez MT, Alvarez NC, Giner Muñoz MT, Hernando Sastre V, Porto Arceo JA, et al. Perioperative anaphylactic reactions: Review and procedure protocol in paediatrics. Allergol Immunopathol (Madr). 2015;43(2):203-14.

47. Dewachter P, Kopac P, Laguna JJ, Mertes PM, Sabato V, Volcheck GW, et al. Anaesthetic management of patients with pre-existing conditions: a narrative review. Br J Anaesth. 2019;123(1):e65-81.

48. Société Française d’Anesthesie et de Réanimation. Société Française d”Allergologie. Reducing the risk of anaphylaxis during anaesthesia. Short text. Ann Fr Anesth Reanim. 2011;30(3):212‑22.

49. Laguna JJ, Archilla J, Doña I, Corominas M, Gastaminza G, Mayorga C, et al. Practical guidelines for perioperative hypersensitivity reactions. J Investig Allergol Immunol. 2018;28(4):216-32.

50. Soares ISC. Sensibilização ao látex em pacientes com mielomeningocele na Urologia do HC-FMUSP: prevalência e fatores associados [tese]. São Paulo; Faculdade de Medicina USP; 2016 doi:10.11606/T.5.2016.tde-20052016-102431.

51. Silva Jr JB. Resolução RDC nº 37, de 26 de agosto de 2015. Ministério da Saúde/Agência Nacional de Vigilância Sanitária/ Diretoria Colegiada. Dispõe sobre a padronização de frases de declaração de conteúdo de látex de borracha natural em rótulos de dispositivos médicos. Diário Oficial da União. Edição 164, Seção 1, Página 46.

52. Mertes PM, Malinovsky JM, Jouffroy L; Working Group of the SFAR and SFA, Aberer W, Tereehorst I, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 update guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21(6):442-53.

53. Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care. 2012;40:216-35.

54. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg. 2003;97:1381-95.

55. Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular response: an in vivo microdialysis study in human skin. Anesth Analg. 2004;98:364‑70.

56. Ebo DG, Fischer MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy. 2007;62:471-87.

57. Nasser SM, Ewan PW. Opiate-sensitivity: clinical characteristics and the role of skin prick testing. Clin Exp Allergy. 2001;31:1014-20.

58. Van Gasse AL, Hagendorens MM, Sabato V, Bridts CH, De Clerck LS, Ebo DG. IgE to poppy seed and morphine are not useful tools to diagnose opiate allergy. J Allergy Clin Immunol. 2015;3:396-9.

59. Baker MTN, Aguib M. Propofol: the challenges of formulation. Anesthesiology. 2005;103:860-76.

60. Asseroj LL, Mosbech H, kroigaard M, Garvey LH. No evidence for contraindications to the use of propofol in adults allergic to egg, soy and peanuts. Br J Anaesth. 2016;116(1):77-82.

61. Murphy A, Campbell DE, Baines D, Mehr S. Allergic reactions to propofol in egg-allergic children. Anesth Analg. 2011;113:140-4.

62. Mehta P, Sundaram SS, Furuta GT, Pan Z, Atkins D, Markowitz S. Propofol use in pediatric patients with food allergy and eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2017;64:546-9.

63. Tacquard C, Collange O, Gomis P, Malinovsky JM, Petipain N, Demoly P, et al. Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiology survey. Acta Anaesthesiol Scand. 2017;61:290-9.

64. Harper NJN, Cook TM, Garcez T, Lucas DN, Thomas M, Kemp H, et al. Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6). Br J Anaesth. 2018;121:172-88.

65. Kvisselgaard AD, Mosbech HF, Fransson S, Garvey LH. Risk of Immediate-type to local anesthetic is overestimated-results from 5 years of provocation testing in a Danish allergy clinic. J Allergy Clin Immunol Pract. 2018;6:1217-23.

66. Kvisselgaard AD, Melchiors BB, Kroigaard M, Garvey LH. Lidocaine as a rare and hidden allergen in the perioperative setting: a case report. Anesth Analg Pract. 2019;12(11):430-2.

67. Bhole MV, Manson AL, Seneviratne SL, Misbah SA. IgE-mediate allergy to local anaesthetic:separating fact from perception: a UK perspective. Br J Anaesth. 2012;108(6):903-11.

68. Malinovsky JM, Chiriac AM, Tacquard C, Mertes PM, Demoly P. Allergy to local anesthetics: Reality or mith? Presse Med. 2016;45(9):753-7.

69. Volcheck GW, Mertes PM. Local and general anesthetics immediate hypersensitivity reactions. Immunol Allergy Clin N Am. 2014;34:525‑46.

70. Rose MA, Garcez T, Savic S, Garvey LH. Chlorhexidine allergy in the perioperative setting: a narrative review. Br J Anaesth. 2019;123(1):e95-e103.

71. Garvey LH, Roed-Petersen J, Husum B. Anaphylactic reactions in anaesthetized patients - four cases of chlorhexidine allergy. Acta Anaesthesiol Scand. 2001;45:1290-4.

72. Opstrup MS, Malling HJ, Kroigaard M, Mosbech H, Skow PS, Poulsen LK, et al. Standardized testing with chlorhexidine in perioperative allergy - a large single - centre evaluation. Allergy. 2014;69(10):1390-6.

73. Palobart C, Cros J, Orsel I, Nathan N. Choc anaphylactique à la povidone iodée. Ann Fr Anesth Reanim. 2009;28:168-70.

74. Dewachter P, Mouton-Faivre C. Allergie aux medicaments et aliments iodés: la sequence allergénique n’est pas l’iode. Presse Med. 2015;44(11):1136-45.

75. Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol. 2012;12:361-8.

76. Garvey LH. Practical aspects of perioperative anaphylaxis. Trends Anaesth Crit Care. 2013;3:320-6.

77. Opstrup MS, Mosbech H, Garvey LH. Allergic sensitization to ethyelene oxide in patients with suspected allergic reactions during surgery and anesthesia. J Investig Allergol Clin Immunol. 2010;20(3):69-70.

78. Garvey LH. Old, new and hidden causes of perioperative hypersensitivity. Curr Pharm Des. 2016;22(45):6814-24.

79. Bache S, Petersen JT, Garvey LH. Anaphylaxis to ethylene oxide - a rare and overlooked phenomenon? Acta Anaesthesiol Scand. 2011;55:1279-82.

80. Listyo A, Hofmaeier KS, Bandschapp O, Erb T, Hasler CC, Bircher AJ. Severe anaphylactic shock due to ethylene oxide in a patient with myelomeningocele: successful exposure prevention and pretreatment with omalizumab. Anesth Analg Case Rep. 2014;2:3-6.

81. Hamad A, Iweala OI, Henderson C, Madan S, Stouffer III GA, Commins SP, et al. Recurrent anaphylaxis during cardiac catheterization. J Allergy Clin Immunol Pract. 2018;6(6):2148‑50.

82. Sokol WN. Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (Ortho phthaladehyde) high level desinfectatnt in 4 patients after ciystoscopy. J Allergy Clin Immunol. 2004;114:392-7.

83. Atiych K, Chitkara A, Achlatis S, Branski RC, Amin MR. Allergic reaction to orthophtalaldehyde following flexible laryngoscope. Laryngoscope. 2015;125:2349-52.

84. Larrauri BJ, Torre MG, Malbran E, Juri MC, Fernández-Romero DS, Málbran A. Anafilaxias y reaccciones alérgicas durante cirurgías y procedimientos médicos. Medicina (Buenos Aires). 2017;77:382-7.

85. Cooper DE, White AA, Werkema AN, Auge BK. Anaphylaxis following cystoscopy with equipment sterilized with Cidex OPA (orthophthalaldehyde): a review of two cases. J Endourol. 2008;22:2181-4.

86. Laxenaire MC, Mertes PM, Goupe d’Etudes des Réactions Anaphylacoïdes Peranesthésiques. Anaphylaxis during anaesthesia. Results of two-year survey in France. Br J Anaesth. 2001;87:549‑58.

87. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to clloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim. 1994;13:301-10.

88. Agarwal NS, Spalding C, Nassef M. Life threating intraoperative anaphylaxis to gelatin in Floseal during pediatric spinal surgery. J Allergy Clin Immunol Pract. 2015;3:110-1.

89. Shah G, Scadding G, Nguyen-Lu N, Wigmore T, Chenzbraun A, Wechalekar K, et al. Perio-perative cardiac arrest with ST elevation secondary to gelofusin anaphylaxis-Kounis syndrome in the anaesthetic room. Int J Cardiol. 2013;164:e22-6.

90. Spencer HT, Hsu JT, McDonald DR, Karlin LL. Intraoperative anaphylaxis to gelatina in topical hemostatic agentes during anterior spinal fusion: a case report. Spine J. 2012;12:e1-6

91. Uyttebroeck A, Sabato V, Bridts CH, De Clerck LS, Ebo DG. Anaphylaxis to sccinylated gelatin in a patient with a meat allergy: galactose-alfa(1,3)-galactose (alfa-gal) as antigenic determinant. J Clin Anesth. 2014;26:574-6.

92. Wilson JM, Platts-Mills TAE. Meat Allergy and allergens. Mol Immunol. 2018;100:107-12.

93. Tacquard C, Boudjedir K, Carlier M, Muller JY, Gornis P, Mertes PM. Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance date. J Allergy Clin Immunol. 2017;140:884-5.

94. Squire JE. Risks of transfusion. South Med J. 2011;104:762-9.

95. Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reaction. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol. 2012;159(2):143-53.

96. Dewachter P, Mouton-Faivre C, Laroche D, Clément O. Allergie immediate aux produits de contraste iodés et prevention des reactions. Rev Med Interne. 2009;30:872-81.

97. Dewachter P, Mouton-Faivre C, Castells M, Hepner DL. Anesthesia in the patient with multiple drug allergies: are all allergies the same? Curr Opin Anesthesiol. 2011;24:320-5.

98. Kuhen A, Hilger C, Lehners-Weber C, Codreanu-Morel F, Morisset M, Metz-Favre C, et al. Identification of enolases and aldolases as important fish allergens in cod, salmon and tuna: component resolved diagnosis using paravalbumin and the new allergens. Clin Exp Allergy. 2013;43:811-22.

99. Lopata AL, O’Hehir RE, Leherer SB. Shellfish allergy. Clin Exp Allergy. 2010;40:850-8.

100. Ruethers T, Taki AC, Johnston EB, Nugraha R, Le TTK, Kalic T, et al. Seafood allergy: a comprehensive review of fish and sellfish allergy. Mol Immunol. 2018;100:28-57.

101. Huang SW. Seafood and Iodine: An Analysis of a Medical Myth. Allergy Asthma Proc. 2005;26(6):468-9.

102. Beaty AD, Lieberman PL, Slavin RG. Seafood allergy and radiocontrast media: are physicians propagating a myth? J Med. 2008;121(2):158.e1-4.

103. Schrijvers R, Breynaert C, Ahmedali Y, Bourrain JL, Demoly P, Chiriac AM. Skin testing for suspected iodinated contrast media hypersensitivity. J Allergy Immunol Pract. 2018;6:1246-54.

104. Torres MJ, Gomez F, Doña I, Rosado A, Mayorga C, Garcia I, et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity to iodinated contrast media. Allergy. 2012;67:929‑35.

105. Dewachter P, Laroche D, Mouton-Faivre C, Boloch-Morot E, Cercueil JP, Metget L, et al. Immediate reactions following iodinated contrast media injection: a study of 38 cases. Eur J Radiol. 2011;77:495-501.

106. Sánchez-Borges M, Aberer W, Brockow K, Celik GE, Cernadas J Greenberger PA, et al. Controversies in drug allergy: radiographic contrast media. J Allergy Clin Pract. 2019;7:60-4.

107. Bartlett MJ, Bynevelt M. Acute contrast reaction management by radiologists: a local audit. Australas Radiol. 2003;47:363-7.

108. Rosado Ingelmo A, Doña Diaz I, Cabãnas Moreno R, Moya Quesada MC, Garcia-Avilés C, García Nuñes I, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-55.

109. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic contrast media-gadolinium chelates. Br J Radiol. 2006;79:386-71.

110. Schiavino D, Murzilli F, Del Ninno M, Buonomo A, Roncallo C, Pollastrini E, et al. Demonstration of an IgE-mediated immunological pathogenesis of a severe adverse reaction to gadopentato dimeglumine. J Investig Allergol Clin Immunol. 2003;13:140-2.

111. Mertes PM, Malinovsky JM, Mouton-Faivre, Bonnet-Boyer MC, Benhaijoub A, Lavaud F, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol. 2008;122:348-52.

112. Ishiyama T, Kotoda M, Asano N, Ikimoto K, Mitisui K, Sato H. Blue dye on peripheral and cerebral oxyhemoglobin saturations. Anaesthesia. 2015;70:429-33.

113. Batti MACSB, Mendes A, Pinheiro JT, Frode TS. Reação alérgica ao azul patente. Rev Bras Anest. 2004;54:180.

114. Xu K, Tzankowa V, Li C, Sharma S. Intravenous fluorescein angiograhy- associated adverse reactions. Can J Ophtalmol. 2016;51(5):321-5.

115. Lee T, Sanderson D, Doyle P, Buchsbaum G. Anaphylactic Shock After Intravenous Fluorescein Administration for Intraoperative Cystoscopy. Obstet Gynecol. 2018;131(4):727-9.

116. Levy JH, Adkinson NF. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg. 2008:106:392-403.

117. Dietrich W, Ebell A, Busley R, Boulesteix AL. Aprotinin and anaphylaxis: analysis of 12.403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg. 2007;84:1144-50.

118. Nybo M, Madsen JS. Serious anaphylactica reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103:192-6.

119. Greenberger PA, Patterson R, Tobin MC, Liotta JL, Roberts M. Lack of cross-reactivity between IgE to salmon and protamine sulfate. Am J Med Sci. 1989;298:104-8.

120. Levy JH, Scwieger IM, Zaidan JR, Faraj BA, Weintraub WS. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg. 1989;98:200-4.

121. Valchanov K, Falter F, George S, Burt C, Roscoe A, Ng C, et al. Three cases of anaphylaxis to protamine: management of anticoagulation reversal. J Cardiothorac Vasc Anesth. 2019;33(2):482-6.

122. Levy JH, Bartz RR. Protamine, is something fishy abaout it? The spectre of anaphylaxis continus. J Cardiothorac Vasc Anesth. 2019;33:487-8.

123. Marinho S, Kemp H, Cook TM, Farmer L, Farooque S, Lucas DN, et al. Cross-sectional study of perioperative drug and allergen exposure in UK practice in 2016: the 6th National Audit Project (NAP6) Allergen Survey. Br J Anaesth. 2018;121(1):146-58.

124. Chiem J, Ivanova I, Parker A, Krengel W 3rd, Jimenez N. Anaphylactic reaction to tranexamic acid in an adolescent undergoing posterior spinal fusion. Paediatr Anaesth. 2017;27(7):774‑5.

125. Li PH, Trigg C, Rutkowski R, Rutkowski K. Anaphylaxis to tranexamic acid - a rare reaction to a common drug. J Allergy Clin Immunol Pract. 2017;5(3):839‑41.

126. Lee HK, Choi EJ, Lee PB, Nahm FS. Anaphylactic shock caused by the epidurally-administered hyaluronidase. Korean J Pain. 2011;24:221-5.

127. Raichura ND, Alam MS, Jaichandran VV, Mistry S, Mukherjee B. Hyaluronidade allergy mimicking orbital cellulitis. Orbit. 2018;37(2):149-53.

128. Alcubierre R, Sanchez-Dalmau BF, Mousavi K. Compressive optic neuropathy secondary toa n allergic reaction to hyaluronidase. Arch Soc Esp Oftalmol. 2019 Sep;94(9):441-4.

129. Halliday L, Sia PI, Durkin S, Selva D. Atypical case of hyaluronidase allergy with orbital compartment syndrome and visual loss. Clin Exp Ophtalmology. 2018;46(5):563-4.

130. Tan P, Malhotra R. Hyaluronic acid fillers and hyaluronidase use in regional eye blocks. Anaesthesia. 2016;71:988-9.

131. Wenande E, Garvey LH. Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy. 2016;46:907‑22.

132. Cerdá VJ, Pacheco RR, Witek JD, de la Calle FMM, Fernández MLS. Immediate hypersensitivity to polyethylene glycols in unrelated products: when standardization in the nomenclature of the components of drugs, cosmetics and food become necessary. Allergy Asthma Clin Immunol. 2019;15:9.

133. Farber MK, Angelo TE, Castells M, Tsen LC. Anesthetic management of patient with an allergy to propylene glycol and parabens. Anesth Analgesia. 2010;110(3):839‑42.

134. Witschi L, Reist L, Stammschulte T, Erlenwein J, Becke K, Stamer U. Perioperative Anwendung von Metamizol und anderen Nichtopioidanalgetika bei KindernPerioperative use of metamizole and other nonopioid analgesics in children. Anaesthesist. 2019;68(3):152‑60.

135. Varalda DB, Motta AA. Adverse reactions to nonsteroidal antiinflammatory. Rev Bras Alerg e Imunopatol. 2009;32:27‑34.

136. Torres MJ, Barrionuevo E, Kowalski M, Blanca M. Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs. Immunol Allergy Clin North Am. 2014;34(3):507‑24.

137. Doña I, Blanca-López N, Cornejo-García JA, Torres MJ, Laguna JJ, Fernández J, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Patterns of response. Clin Exp Allergy. 2011;41(1):86‑95.

138. Wöhrl S. NSAID hypersensitivity – recommendations for diagnostic work up and patient management. Allergo J Int. 2018;27(4):114‑21.

139. Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414‑20.

140. Ensina LF, Bastos PGA, de Lacerda AE, de Araujo CA, CameloNunes I, Solé D. Comments on Balp et al. Pediatr Allergy Immunol. 2018;29(6):669‑70.

141. Lobera TI, Audicana MT, Pozo MD, Blasco A, Fernández E, Cañada P, et al. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain.J Investig Allergol Clin Immunol. 2008;18(5):350‑6.

142. Trautmann A, Seidl C, Stoevesandt J, Seitz CS. General anaesthesia-induced anaphylaxis: Impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy. 2016;46(1):125‑32.

143. Kemp HI, Cook TM, Thomas M, Harper NJN. UK anaesthetists’ perspectives and experiences of severe perioperative anaphylaxis: NAP6 baseline survey. Br J Anaesth. 2017;119(1):132‑9.

144. Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018;121(1):159‑71.

145. Mertes PM, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France seventh epidemiologic survey. Ann Fr Anesth Reanim. 2004;23:1133‑43.

146. Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Messroghli L, et al. Metamizole for postoperative pain therapy in 1177 children: a prospective, multicentre, observational, post authorisation safety study. Eur J Anaesthesiol. 2015;32:839‑43.

147. De Leeuw TG, Dirckx M, Gonzalez C, Andel A, Scoones GP, Huygen FJPM, et al. The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review. Paediatr Anaesth. 2017;27(12):1193-201.

148. Kidon M, Blanca-Lopez N, Gomes E, Terreehorst I, Tanno L, Ponvert C, et al. EAACI/ENDA position paper: diagnosis and management of hypersensitivity reactions to non-steroidal antiinflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469-80.

149. Ansari F, Erntell M, Goossens H, Davey P. The European Surveillance of Antimicrobial Consumption (ESAC) Point‐Prevalence Survey of Antibacterial Use in 20 European Hospitals in 2006. Clin Infect Dis. 2009;49(10):1496‑504.

150. Robert J, Péan Y, Varon E, Bru JP, Bedos JP, Bertrand X, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. 2012;67(4):1020‑6.

151. Garvey LH, Hunter JM. Changing culprits in perioperative anaphylaxis. Br J Anaesth. 2018;121(1):114‑7.

152. Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery and life-threatening allergic reactions: from the Report and findings of the 6th National Audit Project, Royal College of Anaesthetists. Br J Anaesth. 2018 Jul;121(1):159‑71.

153. Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, et al. The 3 Cs of Antibiotic Allergy – Classification, Cross-Reactivity, and Collaboration. J Allergy Clin Immunol Pract. 2017;5(6):1532‑42.

154. Romano A, Warrington R. Antibiotic Allergy. Immunol Allergy Clin North Am. 2014;34(3):489‑506.

155. Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM. Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract. 2015;3(1):101-105.e1.

156. Kuhlen JL, Camargo CA, Balekian DS, Blumenthal KG, Guyer A, Morris T, et al. Antibiotics Are the Most Commonly Identified Cause of Perioperative Hypersensitivity Reactions. J Allergy Clin Immunol Pract. 2016;4(4):697‑704.

157. Savic LC, Garcez T, Hopkins PM, Harper NJN, Savic S. Teicoplanin allergy - An emerging problem in the anaesthetic allergy clinic. Br J Anaesth. 2015;115(4):595‑600.

158. Penicillin Allergy in Antibiotic Resistance Workgroup. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract. 2017;5(2):333‑4.

159. Lucas M, Arnold A, Sommerfield A, Trevenen M, Braconnier L, Schilling A, et al. Antibiotic allergy labels in children are associated with adverse clinical outcomes. J Allergy Clin Immunol Pract. 2019;7(3):975‑82.

160. Macy E, Contreras R. Healthcare utilization and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133:790-6.

161. Vorobeichik L, Weber EA, Tarshis J. Misconceptions surroundingpenicillin allergy: implications for Anesthesiologists. Anest Analg. 2018;127:642‑9.

162. Har D, Solensky R. Penicillin and beta‐lactam hypersensitivity. Immunol Allergy Clin North Am. 2017;37(4):643‑66.

163. Savic LC, Khan DA, Kopac P, Clarke RC, Cooke PJ, Dewachter P, et al. Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations. Br J Anaesth. 2019;123(1):e82-e94.

164. Moussa Y, Shuster J, Matte G, Sullivan A, Goldstein RH, Cunningham D, et al. De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis. Surgery. 2018 May 8. pii: S0039-6060(18)30127-2.

165. Nel L, Eren E. Peri-operative anaphylaxis. Br J Pharmacol. 2011;71(5):647-58.

166. Vitte J, Amadei L, Gouitaa M, Mezouar S, Zieleskiewicz L, Albanese J, et al. Paired acute‐baseline serum tryptase levels in perioperative anaphylaxis: an observational study. Allergy. 2019;74:1157-65.

167. Baretto RL, Beck, S, Heslegrave J, Melchior C, Mohamed O, Ekbote A, et al. Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective. Allergy. 2017;72:2031-4.

168. Laroche D, Gomis P, Gallimidi E, Malinowsky JM, Mertes PM. Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia. Anesthesiology. 2014;121:272-9.

169. Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for thr investigation of suspected anaphylaxis during general anesthesia. Clin Exp Allergy. 2010;40:15-31.

170. Uyttebroek AP, Decuyper II, Bridts CH, Romano A, Hagendorens MM, Ebo DG, et al. Cefazolin Hypersensitivity: Toward Optimized Diagnosis. J Allergy Clin Immunol Pract. 2016;4(6):1232‑6.

171. Opstrup MS, Poulsen LK, Malling HJ, Jensen BM, Garvey LH. Dynamics of specific IgE in chlorhexidine allergic patients with and without accidental re‐exposure. Clin Exp Allergy. 2016;46:1090‑8.

172. Soetens F, Rose M, Fisher M. Timing of skin testing after a suspected anaphylactic reaction during anaesthesia. Acta Anaesthesiol Scand. 2012;56:1042‑6.

173. Mayorga C, Ebo DG, Lang DM, Pichler WJ, Sabato V, Park MA, et al. Controversies in drug allergy: In vitro testing. J Allergy Clin Immunol. 2019;143(1):56-65.

174. Decuyper II, Mangodt EA, Van Gasse AL, Claesen K, Uyttebroek A, Faber M, et al. In vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations. Drugs R D. 2017;17(2):265‑78.

175. Takazawa T, Sabato V, Ebo DG. In vitro diagnostic tests for perioperative hypersensitivity, a narrative review: potential, limitations, and perspectives. Br J Anaesth. 2019;123(1):e117‑e125.

176. Ebo DG, Faber M, Elst J, Van Gasse AL, Bridts CH, Mertens C, et al. In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature. J Allergy Clin Immunol Pract. 2018;6(4):1176‑84.

177. Aun MV, Malaman MF, Felix MMR, Menezes UP, Queiroz GRS, Rodrigues AT, et al. Testes in vivo nas reações de hipersensibilidade a medicamentos - Parte I: testes cutâneos. Arq Asma Alerg Imunol. 2018;2(4):390-8.

178. Aun MV, Malaman MF, Felix MMR, Menezes UP, Queiroz GRS, Rodrigues AT, et al. Testes in vivo nas reações de hipersensibilidade a medicamentos - Parte II: testes de provocação. Arq Asma Alerg Imunol. 2019;3(1):7‑12.

179. Sá AB, Garro LS, Fernandes FR, Rizzo MCV, Sandrin LNA, Ensina LF, et al. Recomendações para o diagnóstico de alergia ao látex. Rev Bras Alerg Imunopatol. 2012;35(5):183-9.

180. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12.

181. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854‑63.

182. Kroigaard M, Garvey LH, Menné T, Husum B. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing? Br J Anaesth. 2005;95(4):486-71.

183. Aun MV, Kalil J, Giavina-Bianchi P. Drug-induced anaphylaxis. Immunol Allergy Clin N Am. 2017;37:629-41.

184. Garvey LH, Ebo DG, Krøigaard M, Savic S, Clarke R, Cooke P, et al. The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status. Br J Anaesth. 2019;123(1):e126-e134.

185. Melchiors BLB, Kroigaard M, Garvey LH. Intravenous provocation with Neuromuscular Blocking Agents in the investigation of perioperative anaphylaxis – preliminary findings from the Danish Anaesthesia Allergy Centre (DAAC). Eur J Anaesthesiol. 2018;35:(suppl 56):318.

186. van Cuilenborg VR, Hermanides J, Bos EME, Hollmann MW, Kooij FO, Terreehorst I. Awake intravenous provocation with small doses of neuromuscular blocking agent in patients with suspected allergy: experiences from the Dutch Perioperative Allergy Centre. Br J Anaesth. 2019;123(1):e153-e155.

187. Laxenaire MC. Management of the allergic patient. Ann Fr Anesth Reanim. 2002;21(6):93-6.

188. Fischer MM, Doig GS. Prevention of anaphylactic reactions to anesthetic drugs. Drug Saf. 2004;27(6):393-410.

189. Simmons FER, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Org J. 2015;8(1):32.

190. Guyer AC, Saff RR, Conroy M, Blumenthal KG, Camargo CA, Long AA, et al. Comprehensive Allergy Evaluation Is Useful in the Subsequent Care of Patients with Drug Hypersensitivity Reactions During Anesthesia. J Allergy Clin Immunol Pract. 2015;3:94-100.

191. Miller J, Clough SB, Pollard RC, Misbah SA. Outcome of repeat anaesthesia after investigation for perioperative anaphylaxis. Br J Anaesth. 2018;120(6):1195-201.

192. Miller J, Misbah SA. Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med. 2015;373(19):1884.

193. Szema A, Paz G, Merriam L, Stellaccio F, Jen J. Modern preoperative and intraoperative management of hereditary angioedema. Allergy Asthma Proc. 2009;30:338‑42.

194. Levy J, Freiberger D, Roback J. Hereditary angioedema: current and emerging treatment options. Anesth Analg. 2010;110:127‑80.

195. Aygoren-Pursun E, Martinez-Saguer I, Kreuz W, Klingebiel T, Schwabe D. Risk of angioedema following invasive or surgical procedures in HAE type I and II - the natural history. Allergy. 2013;68:1034-9.

196. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012;67:147‑57.

197. Farkas H, Zotter Z, Csuka D, Szabo E, Nebenfuhrer Z, Temesszentandrasi G, et al. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor - a long-term survey. Allergy. 2012;67:1586-93.

198. Galan HL, Reedy MB, Starr J, Knight AB. Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report. J Reprod Med. 1996;41:541-4.

199. Birjmohun RS, Kees Hovingh G, Stroes ESG, Hofstra JJ, DallingaThie GM, Meijers JCM, et al. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. Clin Ther. 2008;30(12):2314‑23.

200. Bouillet L, Ponard D, Drouet C, Dumestre C, Pernollet M, Bonerandi JJ, et al. Acquired angioneurotic edema. Clinical and biological characteristics in 9 patients. Presse Med. 2000;29:640‑4.

201. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A. Autoantobodies and lymphoproliferative diseases in acquired C1- inhibitor deficiencies. Medicine (Baltimore). 2003;82(4):274-81.

202. Giavina-Bianchi P, Arruda LK, Aun MV, Campos RA, ChongNeto HJ, Constantino-Silca R, et al. Diretrizes brasileiras para o diagnóstico e tratamento do angioedema hereditário – 2017. Arq Asma Alerg Imunol. 2017;1(1):23-48.

203. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603-25.

204. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226‑32.

205. Bonadonna P, Pagani M, Aberer W, Bilò MB, Brockow K, Oude Elberink H, et al. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy. 2015;70(7):755-63.

206. Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis – a case based review. Pediatr Anesth. 2009;19:97‑107.

207. Dewachter P, Castells MC, Hepner DL, Mouton-Faivre C. Perioperative management of patients with mastocytosis. Anesthesiology. 2014;120(3):753-9.

208. Escribano L, de Gonzalez Olano D, de La Hoz Caballer B, Esteban Lopez I, Sanchez Fernandez I. Mastocitosis: guıas para su diagnostico y tratamiento In: Pelaez Hernandez A, DavilaGonzalez IJ, eds. Tratado de Alergologia. 1ª ed. Madrid: Ergon; 2007. p. 1241‑62.

209. Hermans MAW, Arends NJT, Gerth van Wijk R, van Hagen PM, Kluin-Nelemans HC, Oude Elberink HNG, et al. Management around invasive procedures in mastocytosis: An update. Ann Allergy Asthma Immunol. 2017 Oct;119(4):304-9.

210. Ciach K, Niedoszytko M, Abacjew-Chmylko A, Pabin I, Adamski P, Leszczynska K, et al. Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM). PLoS One. 2016;11(1):e0146924.

211. Carter MC, Uzzaman A, Scott LM, Metcalfe DD, Quezado Z. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg. 2008;107(2):422-7.

212. Sandler SG, Eder AF, Goldman M, Winters JL. The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based. Transfusion. 2015;55:199-204.